Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Molecular Cell|March 3, 2021
Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylationWei Tan, Pei Jiang, Wanjun Zhang, et al.
Oncogene|September 1, 2018
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancerJing Sun, Xin Cai, Mingo Mh Yung, et al.
Ophthalmology|May 5, 2009
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanomaSteven Yeh, Neel K Karne, Sid P Kerkar, et al.
Nature Biomedical Engineering|July 5, 2022
A strain-programmed patch for the healing of diabetic woundsGeorgios Theocharidis, Hyunwoo Yuk, Heejung Roh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian CancerZhuqing Li, Wei Zhou, Yi Zhang, et al.
Cell Death & Disease|April 2, 2021
SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistanceJing Li, Ruiqin Wu, Mingo M H Yung, et al.
Cancer Letters|April 29, 2018
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancerYunxiao Meng, Chi-Wei Chen, Mingo M H Yung, et al.
Advanced Materials Technologies|December 23, 2025
Intelligent In situ Printing of Multimaterial Bioinks for First-Aid Wound Care Guided by Eye-In-Hand Robot TechnologySeol-Ha Jeong, Jihyun Kim, Brendan Craig Thibault, et al.
Journal of Autoimmunity|November 6, 2003
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administrationRobert B Nussenblatt, Darby J S Thompson, Zhuqing Li, et al.
Pageof 11